BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
iShares International Treasury Bond ETF
IGOV
$1.54B
| $25.9M | ﹤0.01% |
504,563
+11,882
| +2% | +$626K |
|
3102
Ryan Specialty Holdings
RYAN
$11B
| $25.9M | ﹤0.01% |
+763,783
| New | +$24.1M |
|
3103
CleanSpark
CLSK
$2.96B
| $25.8M | ﹤0.01% |
2,227,907
-364
| -0% | -$4.9K |
|
3104
iShares ESG Optimized MSCI USA ETF
SUSA
$4.21B
| $25.8M | ﹤0.01% |
268,901
+27,324
| +11% | +$2.7M |
|
3105
Clover Health Investments
CLOV
$2.41B
| $25.8M | ﹤0.01% |
3,486,252
+1,272,861
| +58% | +$10.9M |
|
3106
TC Energy
TRP
$66.3B
| $25.7M | ﹤0.01% |
535,316
-20,712
| -4% | -$1M |
|
3107
CytomX Therapeutics
CTMX
$760M
| $25.7M | ﹤0.01% |
5,052,601
-28,022
| -0.6% | -$150K |
|
3108
Hooker Furnishings Corp
HOFT
$160M
| $25.7M | ﹤0.01% |
952,300
-40,313
| -4% | -$1.29M |
|
3109
MediaAlpha
MAX
$787M
| $25.7M | ﹤0.01% |
1,375,960
+16,678
| +1% | +$452K |
|
|
BLFY
3110
DELISTED
Blue Foundry Bancorp
BLFY
| $25.7M | ﹤0.01% |
+1,863,590
| New | +$25M |
|
3111
Erasca
ERAS
$6.25B
| $25.7M | ﹤0.01% |
+1,208,816
| New | +$24.9M |
|
3112
N-able
NABL
$695M
| $25.6M | ﹤0.01% |
+2,062,142
| New | +$28.3M |
|
|
GRFS
3113
Grifois
GRFS
$5.4B
| $25.6M | ﹤0.01% |
1,750,643
-13,747
| -0.8% | -$208K |
|
3114
Grupo Aeroportuario Centro Norte
OMAB
$5.28B
| $25.5M | ﹤0.01% |
545,194
-56,248
| -9% | -$2.73M |
|
3115
Carter Bankshares
CARE
$749M
| $25.5M | ﹤0.01% |
1,792,571
+25,119
| +1% | +$310K |
|
|
MYOV
3116
DELISTED
Myovant Sciences Ltd.
MYOV
| $25.5M | ﹤0.01% |
1,135,635
+77,322
| +7% | +$1.7M |
|
3117
Arbutus Biopharma
ABUS
$908M
| $25.5M | ﹤0.01% |
5,935,203
+99,630
| +2% | +$332K |
|
|
FRBK
3118
DELISTED
Republic First Bancorp Inc
FRBK
| $25.4M | ﹤0.01% |
8,256,210
-278,146
| -3% | -$967K |
|
3119
RBB Bancorp
RBB
$466M
| $25.3M | ﹤0.01% |
1,002,682
-15,908
| -2% | -$390K |
|
3120
BeyondSpring
BYSI
$41M
| $25.2M | ﹤0.01% |
1,601,971
+183,801
| +13% | +$3.3M |
|
|
TCRR
3121
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $25.2M | ﹤0.01% |
2,964,645
+27,527
| +0.9% | +$389K |
|
3122
Enovix
ENVX
$966M
| $25.2M | ﹤0.01% |
+1,526,352
| New | +$23M |
|
|
HEPS
3123
D-Market Electronic Services & Trading
HEPS
$1.01B
| $25.2M | ﹤0.01% |
+3,674,761
| New | +$40M |
|
3124
iShares Bloomberg Roll Select Commodity Strategy ETF
CMDY
$575M
| $25.2M | ﹤0.01% |
430,585
-19,880
| -4% | -$1.11M |
|
|
IVC
3125
DELISTED
Invacare Corporation
IVC
| $25.1M | ﹤0.01% |
5,281,457
-196,224
| -4% | -$1.43M |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.